SynthesisPloS one2015

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Valérie Devauchelle-Pensec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.